0
United States ( Change Country )

BIIB021

Catalog No.S1175
Price Stock Quantity
$ 120
$ 210
$ 420
$ 770
 
processing...
You can order by phone, email or fax

Tel: +1-832-582-8158    Fax: +1-832-582-8590
Email: sales@selleckchem.com

Free Overnight Delivery on all orders over $ 500.

Order BIIB021 now
and get it on .

BIIB021 Chemical Structure

  • Elesclomol

    HSP-70 Inducer

  • AUY922 (NVP-AUY922)

    NVP-AUY922 (VER-52296) is a highly potent HSP90 inhibitor to HSP90α and HSP90β with IC50 of 13 nM and 21 nM, respectively.

  • 17-AAG (Geldanamycin)

    17-AAG (Geldanamycin) is a less toxic analogue of the geldanamycin which binds to Hsp90 and alters its function.

  • 17-DMAG HCl (Alvespimycin)

    17-DMAG HCl (Alvespimycin) is a selective Hsp90 inhibitor with a GI50 of 53 nM.

  • Ganetespib (STA-9090)

    Ganetespib is a unique triazolone-containing Hsp90 inhibitor with an IC50 of 4 nM for OSA 8 cells.

  • AT13387

    AT13387 is a selective potent small molecule heat shock protein 90 (Hsp90) inhibitor for A375, MV4-11, NCI-H1975 and SKBr3 cell lines with IC50 of 18 nM, 12 nM, 22 nM and 55 nM, respectively.

  • MPC-3100

    MPC-3100 is a fully synthetic potent small-molecule Hsp90 inhibitor with an IC50 of 60 nM.

  • NVP-BEP800

    NVP-BEP800 is a novel, fully synthetic, oral Hsp90 inhibitor with an IC50 of 0.058 ± 0.006 μM.

  • SNX-2112

    SNX-2112 is a potent synthetic heat shock protein 90 inhibitor with an IC50 of 0.92 μM for K562 cells.

  • PF-04929113 (SNX-5422)

    PF-04929113 (SNX-5422) is a potent and selective Hsp90 inhibitor with an IC50 of median 50 nM.

Biological Activity

BIIB021,formerly CNF2024,is a novel fully synthetic inhibitor of Hsp90. It binds competitively with geldanamycin in the ATP-binding pocket of Hsp90 (Ki=1.7nM). [1]In tumor cells, BIIB021 induced the degradation of Hsp90 client proteins (including HER-2, AKT, and Raf-1) and up-regulated expression of the heat shock proteins Hsp70 and Hsp27. BIIB021 inhibits cell growth and death in variety cell lines (breast, colon, lung) at nanomolar concentrations (IC50: 60nM-250nM) [1] .
Oral administration of BIIB021 led to the inhibition of tumor growth in several human tumor xenograft models. BIIB021 is currently in phase I and II clinical trials in hematopoietic malignancies and solid tumors. [1]

References on BIIB021
  • [1] Karen Lundgren, Hong Zhang,et al. 2009;8:921-929
Molecular Weight (WM): 318.76
Formula:

C14H15ClN6O

CAS No.: 848695-25-0
Synonyms:
CNF2024
Dissolve in (25°C): DMSO ≥64mg/mL 
Water <1mg/mL 
Ethanol ≥2mg/mL 
Storage: 2 years-20°CPowder
1 week-4°Cin DMSO
1 month-80°in DMSO

Quality Control & MSDS

View current batch:
COA H-NMR HPLC

Related Inhibitors

Recommended Screening Libraries

Our scientific support team are available to answer any questions or queries.
Fill out an inquiry form for BIIB021 for help.

Free Sample and Reward

We give free samples and rewards to people who would like to provide us useful scientific data(western blot, etc.) > See Details

Recently Viewed Items

Keywords:buy BIIB021 | BIIB021 supplier | purchase BIIB021 | BIIB021 cost | BIIB021 manufacturer | order BIIB021 | BIIB021 distributor